Universal Health Services Inc (UHS) · Oct 27, 2026 · Earnings
In line — Diluted EPS $5.22 vs roughly $5.20-$5.22 consensus
Universal Health Services’ third-quarter earnings were broadly in line, with strong acute-care volume offset by weaker margins, higher debt and rising costs.
UHS is a large acute-care and behavioral-health operator expanding its virtual behavioral-health reach through the Talkspace acquisition completed in August 2026. This quarter shows the core hospital business still producing volume, but not converting that growth into better profitability.
The headline earnings result was essentially in line, not a meaningful beat. Third-quarter diluted EPS was $5.22 versus published estimates clustered around roughly $5.20-$5.22, while revenue of $4.733 billion was close to the roughly $4.71-$4.76 billion expectation range. The filing reports $5.22 of diluted EPS versus $5.86 a year earlier.
| Metric | Q3 2026 | Q3 2025 | Change / comparison |
|---|---|---|---|
| Revenue | $4.733B | $4.495B | +5.3% |
| Diluted EPS | $5.22 | $5.86 | -10.9% |
| Adjusted EBITDA | $624.6M | $670.6M | -6.9% |
| Adjusted EBITDA margin | 13.2% | 14.9% | -170 bps |
| Same-facility acute-care revenue | — | — | +4.7% |
| Same-facility acute-care admissions | — | — | +4.9% |
| Same-facility behavioral-health revenue | — | — | +4.0% |
| Operating cash flow, nine months | $1.481B | $1.290B | +14.9% |
| Debt | $5.707B | $4.691B | Higher year over year |
Demand was the strong part of the quarter, especially in acute care. Same-facility acute-care admissions and patient days both rose 4.9%, but revenue per adjusted admission fell 1.7%, indicating that volume—not pricing or case mix—did most of the work. The filing says, “adjusted admissions (adjusted for outpatient activity) and adjusted patient days each increased by 4.9%.” 〔0〕
The underlying profit trend is weaker than the revenue headline suggests. Adjusted EBITDA declined nearly 7% and margin fell from 14.9% to 13.2%, while reported operating expenses grew faster than revenue. Behavioral health also grew, but its same-facility operating margin compressed as salary and other operating costs increased faster than revenue. This is the main tension in the release: UHS is filling beds and generating sales, but the incremental business is currently less profitable.
Cash generation improved, though the balance sheet is carrying more acquisition and buyback funding. Nine-month operating cash flow rose 14.9% to $1.481 billion, helped by accounts receivable and insurance-related movements. At the same time, debt increased to $5.707 billion from $4.691 billion, leverage rose to 2.17 times adjusted EBITDA, and UHS spent $689.6 million repurchasing shares. The filing also records $1.003 billion of acquisition spending year to date, consistent with the Talkspace expansion and other investments.
The legal settlement is no longer an unknown earnings risk, but its final cost remains undisclosed. UHS recorded a $26 million pre-tax increase to self-insurance reserves tied mainly to the Cumberland litigation, while saying the tentative settlement is largely covered by excess insurance and existing reserves. 〔1〕
Bottom line: UHS met a modest earnings bar, but the more important business signal is mixed: patient volumes are healthy and cash flow is better, yet cost pressure is eroding margins and higher debt raises the execution burden around expansion and buybacks.
Q3 earnings call, October 28
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!